2024 2025 2024 A second meta-analysis, Song et al. (2024), reported, “There was no significant difference in all-cause mortality rate between [ivermectin] and controls.” 2026 Ivermectin reduces COVID-19 risk: real-time meta-analysis of 106 studies. Significantly lower risk is seen for mortality, ventilation, ICU admission, … 2025 2025 These findings are in line with a 2024 systematic review and meta-analysis, which found that ivermectin treatment did not reduce the morbidity … 2025 The researchers believe it is completely plausible, urgent, and necessary to evaluate if ivermectin use reduces the risk of admission to an intensive care unit … 2025 Meta-analyses were conducted and certainty of the evidence was assessed using the GRADE approach and additionally in trial sequential analyses … 2021 2022 2024 2024 Chloroquine, along with hydroxychloroquine, was an early experimental treatment for COVID-19. Neither drug has been useful to prevent or treat SARS-CoV-2 … 2021 Editor Note to article entitled “Ivermectin for treatment of COVID-19: A systematic review and meta-analysis” [Heliyon 10 (2024) e27647]. 2024 The Medical Research Council (UK) has awarded a £ 3.7 million DPFS grant to expand the work led by the Medicine Quality Research Group on … Conclusions: In non-hospitalized COVID-19 patients, ivermectin did not have effect on clinical, non- clinical or safety outcomes versus controls … 2024 2022 Ivermectin meta-analyses highlighted, again, the dangers of fake data · Nature publishes retraction of stem cell studies · More allegations … 2024 2026 No information is available for this page. CNBC\’s Meg Tirrell reports the National Institutes of Health is looking at alternative drugs to see if they work to fight Covid.